Central Africa Ebola Outbreak Approaches 500 Confirmed Cases

The Ebola disease outbreak in Central Africa, primarily affecting the Democratic Republic of Congo (DRC) with spillover into Uganda, continues to escalate, with the total number of confirmed cases nearing 500 across both countries. Health authorities report 452 confirmed cases and 82 deaths in the DRC as of June 4, 2026, alongside 19 confirmed cases and two deaths in Uganda as of June 5.

The outbreak, declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO) on May 17, 2026, is driven by the Bundibugyo virus strain. It originated in Ituri Province in northeastern DRC and has spread to North Kivu and South Kivu provinces, with cross-border transmission confirmed in Uganda.

This marks the 17th Ebola outbreak in the DRC since 1976 and the third involving the Bundibugyo strain. Unlike the more frequently encountered Zaire ebolavirus, for which vaccines and treatments exist, the Bundibugyo variant has no approved specific vaccine or therapeutics, though supportive care and experimental options are being deployed. The case fatality rate currently stands around 18% among confirmed cases.

Initial clusters were identified in health zones such as Bunia, Rwampara, and Mongbwalu in Ituri Province. Rapid spread has been fueled by factors including population displacement due to conflict, mining activities, frequent cross-border movements, and overwhelmed healthcare facilities. Several healthcare workers have been affected, highlighting risks in treatment settings.

Uganda’s cases are linked to travelers from the DRC, with most detections in Kampala. Ugandan authorities have implemented enhanced surveillance, contact tracing, and isolation measures, particularly in border districts including the Kigezi sub-region. Recent updates indicate some patients have recovered and been discharged, demonstrating the effectiveness of early intervention.

The WHO, Africa CDC, and partners have mobilized resources for a comprehensive response. Efforts include strengthening laboratory capacity, community engagement, safe burial practices, and infection prevention in health facilities. A six-month response plan estimated at $518 million has seen significant pledges, focusing on coordination, surveillance, and risk communication.

Challenges persist due to insecurity in affected areas, which hampers access and response activities. Health officials stress the importance of community trust and vigilance to prevent further transmission. No cases have been reported in South Sudan, though it remains on high alert given regional connectivity.

International travel restrictions have been enacted by several countries, including the UAE and others, in response to the outbreak. Travelers are advised to avoid non-essential trips to affected areas and to follow screening protocols upon return.

Uganda’s Ministry of Health and the DRC’s authorities continue daily briefings, urging the public to report suspected symptoms—such as sudden fever, weakness, muscle pain, vomiting, and bleeding—promptly. Emphasis is placed on hand hygiene, avoiding contact with sick individuals or bushmeat, and seeking care at designated treatment centers.

As the situation evolves, experts warn that sustained efforts are critical to curb transmission. Models suggest that without rapid isolation and contact tracing, the outbreak could grow significantly larger. However, successful containment in previous outbreaks provides hope that coordinated action can bring this epidemic under control.

Residents in the Kigezi sub-region and other border areas are encouraged to remain alert and cooperate with health teams. Broader regional stability and investment in health infrastructure will be key to preventing future outbreaks in this vulnerable part of Central Africa.